Advertisement

How Can We Eradicate Pertussis

  • James D. Cherry
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 634)

Introduction

In comparison with other vaccine-preventable diseases, pertussis presents many unique challenges (see Cherry and Heininger, in press). Pertussis occurs in all age groups and immunity following natural disease or vaccination is not long lasting.

Bordetella pertussis: The Organism and Its Pathogenesis

Since its first isolation in 1906 Bordetella pertussis has fascinated microbiologists because it contains many toxins and surface proteins (adhesins), antibody to which might be important in protection (see Mattoo and Cherry, 2005). In general, steps in bacteria pathogenesis involve the following: entry into the host and attachment; evasion or disruption of host defenses; development of damage at the infection site; and establishment of systematic disease by dissemination of organisms or their products. Presented in Table 1 are selected toxins and surface proteins of B. pertussis.
Table 1

Selected virulence factors of Bordetella pertussis

Toxins

Pertussis toxin (PT)

Adenylate...

Keywords

Pertussis Toxin Pertussis Vaccine Bordetella Pertussis Acellular Pertussis Vaccine Pertussis Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Bisgard, K. M., Pascual, F. B., Ehresmann, K. R., et al. 2004. Infant pertussis: who was the source? Pediatr. Infect. Dis. J. 23:985–989.CrossRefGoogle Scholar
  2. Celentano, L.P., Massari, M., Paramatti, D., et al. 2005. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. 9:761–765.Google Scholar
  3. Cherry, J. D., Gornbein J., Heininger, U., et al. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901–1906.PubMedCrossRefGoogle Scholar
  4. Cherry, J. D., Olin, P. 1999. Commentaries: The science and fiction of pertussis vaccines. Pediatrics 104:1381–1384.PubMedCrossRefGoogle Scholar
  5. Cherry, J.D. 2005. The epidemiology of pertussis: A comparison of the epidemiology of the disease pertussis with the epidemiology of bordetella pertussis infection. Pediatr. Infect. Dis. J. 115:1422–1427.Google Scholar
  6. Cherry, J.D. 2006. Epidemiology of Pertussis. Pediatr. Infect. Dis. J. 25:361–362.CrossRefGoogle Scholar
  7. Cherry, J.D., Heininger, U. In press. Pertussis and Other Bordetella Infections. In Textbook of Pediatric Infectious Diseases (6th ed.), eds. R. D. Feigin, J. D. Cherry, G. Demmler, and S. Kaplan. Philadelphia: W.B. Saunders Co.Google Scholar
  8. Hallander, H. O., Reizenstein, I., Renemar, B., et al. 1993. Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis. J. Clin. Microbiol. 31:50–52.PubMedGoogle Scholar
  9. Heininger, U., Klich, K., Stehr, K., et al. 1997. Clinical findings in Bordetella pertussis infections: Results of a prospective multicenter surveillance study. Pediatrics 100: e10. <www.pediatrics.org/cgi/content/full/100/6/e10>
  10. Hodder, S. L., Cherry, J. D., Mortimer, E. A., et al. 2000. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin. Infect. Dis. 31:7–14.PubMedCrossRefGoogle Scholar
  11. Mattoo, S., Cherry, J. D. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326–382.PubMedCrossRefGoogle Scholar
  12. Mink, C. A. M., Cherry, J. D., Christenson, P., et al. 1992. A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14:464–471.PubMedCrossRefGoogle Scholar
  13. Schmitt-Grohè, S., Cherry, J. D., Heininger, U., et al. 1995. Pertussis in German adults. Clin. Infect. Dis. 27:860–866.CrossRefGoogle Scholar
  14. Storsaeter, J., Hallander, H. O., Gustafsson, L., et al. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907–1916.PubMedCrossRefGoogle Scholar
  15. Strebel, P., Nordin, J., Edwards, K., et al. 2001. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995–1996. J. Infect. Dis. 183:1353–1359.PubMedCrossRefGoogle Scholar
  16. Ward, J. I., Cherry, J. D., Chang, S., et al. 2005. Efficacy of an acellular pertussis vaccine among adolescents and adults. New Engl. J. Med. 353:1555–1563.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of PediatricsDavid Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations